Hi, I write from Italy. My mother ha diagnosed with multiple myeloma two weeks ago.
We are facing a crossroad because we must decide if follow the traditional therapy VMP based on Melphalan, Prednisone and Velcade or follow a new therapy based on new drugs as isatuximab lenalidomide and desametasone.
Please, tell me your experience.
Thank you